Conference Coverage
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
Conference Coverage
Long-term impact of childhood trauma explained
Those who experienced childhood trauma also have higher rates of other disorders, including asthma, diabetes, and cardiovascular disease.
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
Conference Coverage
Survey reveals room for improvement in teen substance use screening
Lack of treatment and referral options impedes routine substance use screening in primary care settings.
Conference Coverage
Medications provide best risk-to-benefit ratio for weight loss, says expert
Surgery provides the most weight loss, but has the greatest risk, according to an endocrinology, diabetes, and metabolism professor.
Conference Coverage
Step count–heart rate link confirmed in children
The new findings provide a new means for pediatricians to measure physical fitness.
Conference Coverage
Gender-diverse teens face barriers to physical activity
Lack of facilities and fears of judgment also were cited as barriers to regular physical activity.
Conference Coverage
UTI imaging falls short in some primary care settings
“The authors also showed that older providers and those working in smaller practices are less likely to comply with this particular imaging...
Conference Coverage
New hope for adult children with ‘failure to launch’ syndrome
The novel program focuses on reducing parents’ family accommodation, a descriptor for a child’s excessive dependence on their parents to help them...
Conference Coverage
Remote weight monitoring minimizes office visits for newborns
Remote monitoring can help alert physicians earlier to insufficient weight because parents reported gains or losses three times a week over 6...
Conference Coverage
PARP/ATR inhibitor combo shows hints of promise in children with tumors
A phase 1 clinical trial could provide biomarker clues to help guide future studies.